Department of Biochemistry and Molecular Biology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh.
Int J Mol Sci. 2023 May 22;24(10):9088. doi: 10.3390/ijms24109088.
Disease modeling in non-human subjects is an essential part of any clinical research. To gain proper understanding of the etiology and pathophysiology of any disease, experimental models are required to replicate the disease process. Due to the huge diversity in pathophysiology and prognosis in different diseases, animal modeling is customized and specific accordingly. As in other neurodegenerative diseases, Parkinson's disease is a progressive disorder coupled with varying forms of physical and mental disabilities. The pathological hallmarks of Parkinson's disease are associated with the accumulation of misfolded protein called α-synuclein as Lewy body, and degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc) area affecting the patient's motor activity. Extensive research has already been conducted regarding animal modeling of Parkinson's diseases. These include animal systems with induction of Parkinson's, either pharmacologically or via genetic manipulation. In this review, we will be summarizing and discussing some of the commonly employed Parkinson's disease animal model systems and their applications and limitations.
在非人类研究对象中进行疾病建模是任何临床研究的重要组成部分。为了正确了解任何疾病的病因和病理生理学,需要实验模型来复制疾病过程。由于不同疾病的病理生理学和预后存在巨大差异,因此动物建模是定制化和特定的。与其他神经退行性疾病一样,帕金森病是一种进行性疾病,伴有不同形式的身体和精神残疾。帕金森病的病理特征与称为α-突触核蛋白的错误折叠蛋白的积累有关,称为路易体,以及黑质致密部(SNc)区域的多巴胺能神经元退化,影响患者的运动活动。已经对帕金森病的动物模型进行了广泛的研究。这些包括通过药理学或遗传操作诱导帕金森病的动物系统。在这篇综述中,我们将总结和讨论一些常用的帕金森病动物模型系统及其应用和局限性。